首页> 外国专利> COMPOSITION OF SOLID PHARMACEUTICAL PREPARATION CONTAINING TACROLIMUS USING SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEM

COMPOSITION OF SOLID PHARMACEUTICAL PREPARATION CONTAINING TACROLIMUS USING SELF-MICROEMULSIFYING DRUG DELIVERY SYSTEM

机译:自微药物输送系统的含滑石质固体药物制剂的组成

摘要

PURPOSE: A solid formulation composition for oral administration of tacrolimus is provided to improve the bioavailability of tacrolimus without inconvenience. CONSTITUTION: A solid formulation composition for oral administration of tacrolimus contains: a base composition of a self micro-emulsifying drug delivery system containing 30-90 wt% of caproyl caprylic macrogol glyceride as a surfactant, 5-45 wt% of propylene glycol caprylate or triglycerides or a mixture thereof, and 5-60 wt% of diethylene glycol monoethyl ether; 0.1-5.3 weight parts of tacrolimus; and 10-60 parts by weight of dioxy silicone.
机译:目的:提供用于他克莫司口服给药的固体制剂组合物,以改善他克莫司的生物利用度而不会带来任何不便。组成:口服他克莫司的固体制剂组合物包含:自身微乳化药物递送系统的基础组合物,其包含30-90 wt%的己酰基辛酸聚乙二醇甘油酯作为表面活性剂,5-45 wt%的丙二醇辛酸酯或甘油三酸酯或其混合物,和5-60wt%的二甘醇单乙醚;他克莫司的0.1-5.3重量份;和10-60重量份的二氧硅氧烷。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号